Evaluating Effectiveness and Safety in Chronic Kidney Disease with Atrial Flutter Using an Anticoagulation Strategy

Background and objectives: Recent randomized trials of oral antithrombotic drugs with atrial flutter (AFL) excluded patients with renal impairment because of their increased risk of bleeding. To date, no relevant studies have assessed the effectiveness and safety of different antithrombotic drugs in...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ying-Ting, Chen, Chung-Yu, Bair, Ming-Jong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7353883/
https://www.ncbi.nlm.nih.gov/pubmed/32481685
http://dx.doi.org/10.3390/medicina56060266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7353883/
https://www.ncbi.nlm.nih.gov/pubmed/32481685
http://dx.doi.org/10.3390/medicina56060266

Ejemplares similares